1) Corus Cad
Heart disease is the leading cause of death for men and women in the United States. This year, more than 1.2 million people will have a heart attack. While there are warning signs and risk factors, heart disease can hit anyone.
Heart attacks and other types of heart disease occur when coronary arteries become clogged with fatty deposits, resulting in coronary artery disease (CAD). Until recently there was no way, outside of traditional imaging tests, to measure artery health, but a new test is changing all that. Imaging scans are invasive and expose people to radiation, limiting their use.
Corus CAD by Cardio Dx is a gene expression test that uses messenger RNA from a gene set in blood cells to determine whether or not patients have coronary artery blockages. Patients are given a simple blood test that delivers a score on a scale of one to 40. “If they score between one and 15 trial evidence shows that the likelihood of that person having blockage is low,” says Deborah L. Kilpatrick, Ph.D., chief commercial officer of Cardio Dx. The higher your score, the more likely you are to have blockages. This knowledge enables your physician to take extra precautions and book follow-up tests that can potentially save your life.
Who should get the test: Any nondiabetic patient with typical or atypical symptoms of coronary artery disease—regardless of age.
Cost: $1,195; covered by some insurance companies (but if you are uninsured, patient assistance is available).